title: Evaluation of a High-Throughput Peptide Reactivity Format Assay for Assessment of the Skin Sensitization Potential of Chemicals.
abstract: The direct peptide reactivity assay (DPRA) is a validated method for in vitro assessment of the skin sensitization potential of chemicals. In the present work, we describe a peptide reactivity assay using 96-well plate format and systematically identified the optimal assay conditions for accurate and reproducible classification of chemicals with known sensitizing capacity. The aim of the research is to ensure that the analytical component of the peptide reactivity assay is robust, accurate, and reproducible in accordance with criteria that are used for the validation of bioanalytical methods. Analytical performance was evaluated using quality control samples (QCs; heptapeptides at low, medium, and high concentrations) and incubation of control chemicals (chemicals with known sensitization capacity, weak, moderate, strong, extreme, and non-sensitizers) with each of three synthetic heptapeptides, viz Cor1-C420 (Ac-NKKCDLF), cysteine- (Ac-RFAACAA), and lysine- (Ac-RFAAKAA) containing heptapeptides. The optimal incubation temperature for all three heptapeptides was 25°C. Apparent heptapeptide depletion was affected by vial material composition. Incubation of test chemicals with Cor1-C420, showed that peptide depletion was unchanged in polypropylene vials over 3-days storage in an autosampler but this was not the case for borosilicate glass vials. For cysteine-containing heptapeptide, the concentration was not stable by day 3 post-incubation in borosilicate glass vials. Although the lysine-containing heptapeptide concentration was unchanged in both polypropylene and borosilicate glass vials, the apparent extent of lysine-containing heptapeptide depletion by ethyl acrylate, differed between polypropylene (24.7%) and glass (47.3%) vials. Additionally, the peptide-chemical complexes for Cor1-C420-cinnamaldehyde and cysteine-containing heptapeptide-2, 4-dinitrochlorobenzene were partially reversible during 3-days of autosampler storage. These observations further highlight the difficulty in adapting in vitro methods to high-throughput format for screening the skin sensitization potential of large numbers of chemicals whilst ensuring that the data produced are both accurate and reproducible.
authors.affiliation: Centre for Integrated Preclinical Drug Development, The University of QueenslandSt Lucia, QLD, Australia; School of Pharmacy, The University of QueenslandWoolloongabba, QLD, Australia.
authors.forename: Chin Lin
authors.initials: CL
authors.lastname: Wong
authors.affiliation: Centre for Integrated Preclinical Drug Development, The University of Queensland St Lucia, QLD, Australia.
authors.forename: Ai-Leen
authors.initials: AL
authors.lastname: Lam
authors.affiliation: Centre for Integrated Preclinical Drug Development, The University of QueenslandSt Lucia, QLD, Australia; School of Pharmacy, The University of QueenslandWoolloongabba, QLD, Australia.
authors.forename: Maree T
authors.initials: MT
authors.lastname: Smith
authors.affiliation: Centre for Integrated Preclinical Drug Development, The University of Queensland St Lucia, QLD, Australia.
authors.forename: Sussan
authors.initials: S
authors.lastname: Ghassabian
keywords: Cor1-C420; allergic contact dermatitis; cysteine; in vitro methods; lysine; peptide reactivity assay; skin sensitization